ID   RUCH-3
AC   CVCL_C541
SY   RUCH3; Ruch3; Rhabdomyosarcoma of University Children's Hospital-3
DR   Cosmic; 687963
DR   GEO; GSM219746
DR   PRIDE; PXD039480
DR   Wikidata; Q54951464
RX   DOI=10.3929/ethz-a-003884990;
RX   PubMed=12904596;
RX   PubMed=19235922;
RX   PubMed=23882450;
RX   PubMed=36768928;
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
RX   DOI=10.3929/ethz-a-003884990;
RA   Scholl F.A.;
RT   "Identification and characterization of proteins involved in tumor
RT   formation and progression.";
RL   Thesis PhD (2000); Swiss Federal Institute of Technology Zurich; Zurich; Switzerland.
//
RX   PubMed=12904596; DOI=10.1203/01.PDR.0000086901.29111.2A;
RA   Kleideiter E., Schwab M., Friedrich U., Koscielniak E., Schafer B.W.,
RA   Klotz U.;
RT   "Telomerase activity in cell lines of pediatric soft tissue
RT   sarcomas.";
RL   Pediatr. Res. 54:718-723(2003).
//
RX   PubMed=19235922; DOI=10.1002/gcc.20655;
RA   Missiaglia E., Selfe J., Hamdi M., Williamson D., Schaaf G., Fang C.,
RA   Koster J., Summersgill B.M., Messahel B., Versteeg R.,
RA   Pritchard-Jones K., Kool M., Shipley J.M.;
RT   "Genomic imbalances in rhabdomyosarcoma cell lines affect expression
RT   of genes frequently altered in primary tumors: an approach to identify
RT   candidate genes involved in tumor development.";
RL   Genes Chromosomes Cancer 48:455-467(2009).
//
RX   PubMed=23882450; DOI=10.3389/fonc.2013.00183; PMCID=PMC3713458;
RA   Hinson A.R.P., Jones R., Crose L.E.S., Belyea B.C., Barr F.G.,
RA   Linardic C.M.;
RT   "Human rhabdomyosarcoma cell lines for rhabdomyosarcoma research:
RT   utility and pitfalls.";
RL   Front. Oncol. 3:183.1-183.12(2013).
//
RX   PubMed=36768928; DOI=10.3390/ijms24032601; PMCID=PMC9917031;
RA   Timpanaro A., Piccand C., Uldry A.-C., Bode P.-K., Dzhumashev D.,
RA   Sala R., Heller M., Rossler J., Bernasconi M.;
RT   "Surfaceome profiling of cell lines and patient-derived xenografts
RT   confirm FGFR4, NCAM1, CD276, and highlight AGRL2, JAM3, and L1CAM as
RT   surface targets for rhabdomyosarcoma.";
RL   Int. J. Mol. Sci. 24:2601.1-2601.28(2023).
//